EBS is the official New York Stock Exchange ticker symbol for Emergent BioSolutions Inc., representing ownership in a publicly traded specialty pharmaceutical and biodefense enterprise. Shareholders in EBS participate in the corporate financial performance, earnings results, and asset valuation of a company that develops medical countermeasures, vaccines, and emergency health solutions primarily deployed across government and institutional stockpiles.